S. Szymanski

3.4k citations

37 papers · 2.6k indexed · 1 hit paper · h-index 19

Impact in

Psychiatry and Mental health top 0.5%
- Schizophrenia research and treatment
- Bipolar Disorder and Treatment
- Electroconvulsive Therapy Studies
Biological Psychiatry top 2%
- Tryptophan and brain disorders

Papers in

Psychiatry and Mental health 29
- Schizophrenia research and treatment 29
- Bipolar Disorder and Treatment 8
- Electroconvulsive Therapy Studies 5
- Attention Deficit Hyperactivity Disorder 2
Philosophy 9
- Mental Health and Psychiatry 9

Co-authors: Jeffrey A. Lieberman David Mayerhoff John M. Kane José Alvir Antony Loebel Stephan Geisler Allan Z. Safferman J.A. Lieberman
Journals: Schizophrenia Research (10 papers)American Journal of Psychiatry (7 papers)Biological Psychiatry (5 papers)Schizophrenia Bulletin (3 papers)Neuropsychopharmacology (1 paper)
Partner nations: United States Germany Japan

In The Last Decade

S. Szymanski

37 papers receiving 2.4k citations

Hit Papers

align trajectories log scale

Duration of psychosis and outcome in first-episode schizophrenia 1992 · 663 citations

Peers

Countries citing papers authored by S. Szymanski

Since Specialization

Citations

This map shows the geographic impact of S. Szymanski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Szymanski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Szymanski more than expected).

Fields of papers citing papers by S. Szymanski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Szymanski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Szymanski. The network helps show where S. Szymanski may publish in the future.

Co-authors

The 25 scholars most cited alongside S. Szymanski, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with S. Szymanski Line = papers co-authored together S. Szymanski links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Determinants of Utilization of Prone Positioning for Severe Acute Respiratory Distress Syndrome Jennifer C. Ginestra, Tamar Klaiman, C. N. S. McLachlan, Tamara Kaluža Pocecco, Karen Wilkie, S. Szymanski, Tam Tran, Meghan B. Lane‐Fall, Meeta Prasad Kerlin	2020	2
2	Elevated Intrasynaptic Dopamine Release in Tourette’s Syndrome Measured by PET American Journal of Psychiatry ·Harvey S. Singer, S. Szymanski, Joseph Giuliano, Fuji Yokoi, Alexsander I. Zaitsev, James Robert Brašić, Yun Zhou, Anthony A. Grace, Dean F. Wong	2002	190
3	Dopamine Transporter Changes in Neuropsychiatric Disorders Advances in pharmacology ·Dean F. Wong, G.A. Ricaurte, Gerhard Gründer, Richard E. Rothman, S. Naidu, Harvey S. Singer, James C. Harris, Fuji Yokoi, Victor L. Villemagne, S. Szymanski, Albert Gjedde, JA Doyle	1997	20
4	Vulnerability to Tardive Dyskinesia Development in Schizophrenia: An FDG-PET Study of Cerebral Metabolism Neuropsychopharmacology ·S. Szymanski	1996	15
5	Gender differences in neuroleptic nonresponsive clozapine-treated schizophrenics Biological Psychiatry ·S. Szymanski, Jeffrey A. Lieberman, Simcha Pollack, John M. Kane, Allan Z. Safferman, Justin Whitten, Daniel Umbricht, Margaret G. Woerner, В.Н. Годин, Michael H. Kronig	1996	55
6	Clozapine effects on neuroendocrine response to apomorphine challenge testing in chronic neuroleptic nonresponsive schizophrenia: Preliminary findings Biological Psychiatry ·S. Szymanski, Jeffrey A. Lieberman, Simcha Pollack, Allan Z. Safferman, Juan Velásquez M, Daniel Umbricht, John M. Kane, Michael H. Kronig, Miranda Chakos, T B Cooper	1995	11
7	Increased vulnerability to tardive dyskinesia development inschizophrenics with cortical metabolic dysfunction Biological Psychiatry ·S. Szymanski, R.C. Gur, Fiona Gallacher, Doğukan Bayındır, Raquel E. Gur	1995	1
8	Clozapine, negative symptoms, and extrapyramidal side effects. PubMed ·John M. Kane, Allan Z. Safferman, Simcha Pollack, Celeste A. Johns, S. Szymanski, Michael H. Kronig, J.A. Lieberman	1994	23
9	Clozapine response in treatment-refractory first-episode schizophrenia Biological Psychiatry ·S. Szymanski, В.Н. Годин, David Mayerhoff, A. Loebel, S. Geisler, Simcha Pollack, John M. Kane, Jeffrey A. Lieberman	1994	29
10	The dopamine-serotonin relationship in clozapine response Psychopharmacology ·S. Szymanski, Jeffrey A. Lieberman, Simcha Pollack, Justin Whitten, Allan Z. Safferman, John M. Kane, Michael H. Kronig, T B Cooper	1993	24
11	Predictors of response to clozapine in chronic schizophrenia Schizophrenia Research ·Allan Z. Safferman, J.A. Lieberman, Simcha Pollack, S. Szymanski, В.Н. Годин, Celeste A. Johns	1993	1
12	Methylphenidate increases thought disorder in recent onset schizophrenics, but not in normal controls Biological Psychiatry ·Deborah L. Levy, Melissa J. Smith, Delbert G. Robinson, D. Jody, Gail Lerner, José Alvir, Stephen Geisler, S. Szymanski, Alberto González-Aguilar, David Mayerhoff, Jeffrey A. Lieberman, Nancy R. Mendell	1993	39
13	Consistency of treatment response across successive psychotic episodes in recent-onset schizophrenia Schizophrenia Research ·A. Loebel, J.A. Lieberman, José Alvir, 茂樹本田, S. Szymanski, David Mayerhoff	1993	5
14	High plasma clozapine levels in tardive dyskinesia. PubMed ·Simcha Pollack, Jeffrey A. Lieberman, David E. Kleiner, S. Szymanski, John M. Kane, Michael Borenstein, Thomas B. Cooper	1993	8
15	Prospective Study of Psychobiology in First-episode Schizophrenia at Hillside Hospital Schizophrenia Bulletin ·J.A. Lieberman, José Alvir, Margaret G. Woerner, Gustav Degreef, Robert M. Bilder, Manzar Ashtari, David Mayerhoff, S. Geisler, Antony Loebel, Gregory A. Hinrichsen, S. Szymanski, Miranda Chakos, A. Koreen, Michael Borenstein, John M. Kane, B. Bogerts, Deborah L. Levy	1992	133
16	The deficit state in a prospective study of first-episode schizophrenia Schizophrenia Research ·David Mayerhoff, Antony Loebel, S. Geisler, S. Szymanski, Michael Borenstein, J.A. Lieberman	1992	3
17	Gadolinium-DTPA enhanced gradient echo magnetic resonance scans in first episode of psychosis and chronic schizophrenic patients Psychiatry Research Neuroimaging ·S. Szymanski, Manzar Ashtari, Joseph Zito, Gustav Degreef, Bernhard Bogerts, Jeffrey A. Lieberman	1991	7
18	A Selective Review of Biological Markers in Schizophrenia Schizophrenia Bulletin ·S. Szymanski, John M. Kane, J.A. Lieberman	1991	38
19	Update on the Clinical Efficacy and Side Effects of Clozapine Schizophrenia Bulletin ·Allan Z. Safferman, Jeffrey A. Lieberman, John M. Kane, S. Szymanski, Bruce J. Kinon	1991	224
20	A pocket reference for psychiatrists Medical Entomology and Zoology ·Susan Jenkins, Alice Giannotti, S. Szymanski	1990	8

About S. Szymanski

S. Szymanski is a scholar working on Psychiatry and Mental health, Philosophy, Biological Psychiatry, Cognitive Neuroscience and Neurology, having authored 37 papers that have together received 2.6k indexed citations. Recurring topics across this work include Schizophrenia research and treatment (29 papers), Mental Health and Psychiatry (9 papers), Bipolar Disorder and Treatment (8 papers), Obsessive-Compulsive Spectrum Disorders (5 papers), Electroconvulsive Therapy Studies (5 papers), Functional Brain Connectivity Studies (5 papers), Treatment of Major Depression (3 papers) and Attention Deficit Hyperactivity Disorder (2 papers). The work is most often cited by research in Psychiatry and Mental health (2.0k citations), Biological Psychiatry (193 citations), Philosophy (755 citations), Clinical Psychology (746 citations) and Cellular and Molecular Neuroscience (334 citations). S. Szymanski has collaborated with scholars based in United States, Germany and Japan. Frequent co-authors include Jeffrey A. Lieberman, David Mayerhoff, John M. Kane, José Alvir, Antony Loebel, Stephan Geisler, Allan Z. Safferman, J.A. Lieberman, Simcha Pollack and Michael H. Kronig. Their work appears in journals such as Schizophrenia Research, American Journal of Psychiatry, Biological Psychiatry, Schizophrenia Bulletin and Neuropsychopharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact